Kimberly-Clark (KMB) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$16.6B

Revenue (quarter)

$4.2B

Revenue growth (year over year)

+0.62%

Gross profit (trailing twelve months)

$6.1B

Gross margin

36.76%

Net income (trailing twelve months)

$2.0B

Net income (quarter)

$350.0M

Net income growth (year over year)

−31.64%

Net margin

11.99%

Return on equity

128.49%

EPS (trailing twelve months)

$5.89

Book value per share

$5.33

P/E (trailing twelve months)

16.91

Price to book

17.44

Debt to assets

89.78%

Payout ratio

62.06%

Dividend yield

5.12%

Company profile

With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide workplace safety and sanitation solutions. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America. It is slated to add Kenvue's consumer health portfolio to its mix in the second half of calendar year 2026.

• Is Kimberly-Clark (KMB) profitable?

  Yes. Kimberly-Clark earned $2.0B in net income over the trailing twelve months, a net margin of 11.99%.

• How much revenue does Kimberly-Clark (KMB) make?

  Kimberly-Clark generated $16.6B in revenue over the trailing twelve months, up 0.62% year over year.

• What is KMB's P/E ratio?

  Kimberly-Clark trades at 16.9 times trailing twelve-month earnings, on an EPS of $5.89.

• How do I buy stock in Kimberly-Clark (KMB)?

  KMB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.